ERS/EACTS statement on the management of malignant pleural effusions

AC Bibby, P Dorn, I Psallidas, JM Porcel… - European journal of …, 2019 - academic.oup.com
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer

G Reid, SC Kao, N Pavlakis, H Brahmbhatt… - …, 2016 - Taylor & Francis
miRNAs are responsible for post-transcriptional control of gene expression, and are
frequently downregulated in cancer. It has become well established that restoring miRNA …

The impact of hemolysis on cell-free microRNA biomarkers

MB Kirschner, JJB Edelman, SCH Kao… - Frontiers in …, 2013 - frontiersin.org
Cell-free microRNAs in plasma and serum have become a promising source of biomarkers
for various diseases. Despite rapid progress in this field, there remains a lack of consensus …

[HTML][HTML] Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

G Reid, ME Pel, MB Kirschner, YY Cheng… - Annals of …, 2013 - Elsevier
Background Malignant pleural mesothelioma (MPM) is recalcitrant to treatment and new
approaches to therapy are needed. Reduced expression of miR-15/16 in a range of cancer …

Malignant pleural mesothelioma: history, controversy, and future of a man-made epidemic

OD Røe, GM Stella - Asbestos and Mesothelioma, 2017 - Springer
Asbestos (Greek, inextinguishable) is the term of a family of naturally occurring minerals that
have been used in small scale since ancient times. Industrialization demanded increased …

[HTML][HTML] Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma

SC Kao, YY Cheng, M Williams, MB Kirschner… - Journal of Thoracic …, 2017 - Elsevier
Introduction The upregulation of programmed death ligand 1 (PD-L1) is found in many
cancers and contributes to evasion of the host's immune defense. In malignant pleural …

[HTML][HTML] Consensus report of the 2015 Weinman international conference on mesothelioma

M Carbone, S Kanodia, A Chao, A Miller, A Wali… - Journal of thoracic …, 2016 - Elsevier
Abstract On November 9 and 10, 2015, the International Conference on Mesothelioma in
Populations Exposed to Naturally Occurring Asbestiform Fibers was held at the University of …

[HTML][HTML] Current and future management of malignant mesothelioma: a consensus report from the national cancer institute thoracic malignancy steering committee …

AS Tsao, OW Lindwasser, AA Adjei… - Journal of Thoracic …, 2018 - Elsevier
Abstract On March 28–29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy
Steering Committee, International Association for the Study of Lung Cancer, and …

MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer

AA Hamidi, N Taghehchian, Z Basirat, AS Zangouei… - Biomarker …, 2022 - Springer
Thyroid cancer (TC) is one of the most frequent endocrine malignancies that is more
common among females. Tumor recurrence is one of the most important clinical …

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

I Opitz, A Scherpereel, T Berghmans… - European journal of …, 2020 - academic.oup.com
Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …